Drugs / Legalon® SIL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01871662 | Aug 2013 → Feb 2016 | chronic hepatitis C virus infection | Rottapharm | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Legalon SIL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01871662 ↗ |
| Known as | Silibinin | “Randomized Study for the Assessment of Silibinin (Legalon® SIL) in the Treatment of naïve Genotype 4 Patients With Chronic Hepatitis C” NCT01871662 ↗ |